Données cliniques, épidémiologiques et biochimiques sur le système de retour du cholestérol (cholestérol-HDL)

Schaefer, 1980, Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease), Ann Intern Med, 93, 261, 10.7326/0003-4819-93-2-261 Francis, 1995, Defective removal of cellular cholesterol and phospholipid by apolipoprotein A-I in Tangier diease, J Clin Invest, 96, 78, 10.1172/JCI118082 Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat Genet, 22, 347, 10.1038/11914 Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat Genet, 22, 336, 10.1038/11905 Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat Genet, 22, 352, 10.1038/11921 Acton, 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science, 271, 518, 10.1126/science.271.5248.518 Marcil, 1999, Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux, Lancet, 354, 1341, 10.1016/S0140-6736(99)07026-9 Goldbourt, 1997, Y aari S., Medalie J.H. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8 000 men, Arterioscler Thromb Vasc Biol, 17, 107, 10.1161/01.ATV.17.1.107 Rubins, 1999, Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol : Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group, N Engl J Med, 341, 410, 10.1056/NEJM199908053410604 The BIP Study Group, 2000, Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary heart disease : the Bezafibrate Infarction Prevention (BIP) Study, Circulation, 102, 21, 10.1161/01.CIR.102.1.21 Haffner, 2000, Secondary prevention of coronary heart disease. The role of fibric acids, Circulation, 102, 2, 10.1161/01.CIR.102.1.2